ARCHIVES

Alimta Reduces Risk Of Progression In Patients Aged 70 Years or Older

This article is from The Cancer Letter archive.

Vol. 34 No. 10 | October 28, 2011

Download PDF Visit The Full Archive

Related Articles

RAS Mutations Can Predict Resistance To Vectibix, FOLFOX Combination Treatment

September 27, 2013

Neurocognitive Deficits Affect Future Adult Employment

September 30, 2011

Senate Approves 15% Increase For NIH; House Passes 5.6% Raise, But Favors More.

July 7, 2000

AOR And PRN, Two Largest Oncology Practice Management Firms, To Merge

December 18, 1998

Phase III Trial Data: Lenvatinib Extends PFS by Over 14 Months

June 27, 2014

In Brief: Special Meeting To Review Viral Oncology Asked by DCCP Board; BCTF Budget: $8 Million

October 31, 1980